ATE224443T1 - Mch2, eine apoptotische cystein-protease, zusammensetzungen für ihre präparation und methoden für ihre verwendung - Google Patents
Mch2, eine apoptotische cystein-protease, zusammensetzungen für ihre präparation und methoden für ihre verwendungInfo
- Publication number
- ATE224443T1 ATE224443T1 AT96920234T AT96920234T ATE224443T1 AT E224443 T1 ATE224443 T1 AT E224443T1 AT 96920234 T AT96920234 T AT 96920234T AT 96920234 T AT96920234 T AT 96920234T AT E224443 T1 ATE224443 T1 AT E224443T1
- Authority
- AT
- Austria
- Prior art keywords
- mch2
- disclosed
- alpha
- beta
- nucleic acid
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 230000001640 apoptogenic effect Effects 0.000 title abstract 2
- 102100027373 Melanin-concentrating hormone receptor 2 Human genes 0.000 title 1
- 101710089759 Melanin-concentrating hormone receptor 2 Proteins 0.000 title 1
- 108091005804 Peptidases Proteins 0.000 title 1
- 239000004365 Protease Substances 0.000 title 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 title 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 101150047706 CASP6 gene Proteins 0.000 abstract 11
- 108020004707 nucleic acids Proteins 0.000 abstract 4
- 102000039446 nucleic acids Human genes 0.000 abstract 4
- 150000007523 nucleic acids Chemical class 0.000 abstract 4
- 239000002773 nucleotide Substances 0.000 abstract 4
- 125000003729 nucleotide group Chemical group 0.000 abstract 4
- 235000018102 proteins Nutrition 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108010005843 Cysteine Proteases Proteins 0.000 abstract 1
- 108091034117 Oligonucleotide Proteins 0.000 abstract 1
- 102000001708 Protein Isoforms Human genes 0.000 abstract 1
- 108010029485 Protein Isoforms Proteins 0.000 abstract 1
- 239000012190 activator Substances 0.000 abstract 1
- 230000000692 anti-sense effect Effects 0.000 abstract 1
- 101150055276 ced-3 gene Proteins 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000003259 recombinant expression Methods 0.000 abstract 1
- 239000000758 substrate Substances 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6472—Cysteine endopeptidases (3.4.22)
- C12N9/6475—Interleukin 1-beta convertase-like enzymes (3.4.22.10; 3.4.22.36; 3.4.22.63)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Detergent Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/446,925 US5672500A (en) | 1995-05-18 | 1995-05-18 | Mch2, an apoptotic cysteine protease, and compositions for making and methods of using the same |
| PCT/US1996/007010 WO1996036698A1 (en) | 1995-05-18 | 1996-05-16 | Mch2, AN APOPTOTIC CYSTEINE PROTEASE, AND COMPOSITIONS FOR MAKING AND METHODS OF USING THE SAME |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE224443T1 true ATE224443T1 (de) | 2002-10-15 |
Family
ID=23774339
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96920234T ATE224443T1 (de) | 1995-05-18 | 1996-05-16 | Mch2, eine apoptotische cystein-protease, zusammensetzungen für ihre präparation und methoden für ihre verwendung |
Country Status (8)
| Country | Link |
|---|---|
| US (4) | US5672500A (de) |
| EP (1) | EP0842267B1 (de) |
| JP (1) | JPH11505705A (de) |
| AT (1) | ATE224443T1 (de) |
| CA (1) | CA2221409C (de) |
| DE (1) | DE69623786T2 (de) |
| ES (1) | ES2183960T3 (de) |
| WO (1) | WO1996036698A1 (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7097972B1 (en) | 1995-02-13 | 2006-08-29 | Regents Of The University Of Michigan | Method and composition for regulating apoptosis |
| US6015665A (en) * | 1995-02-13 | 2000-01-18 | The Regents Of The University Of Michigan | Method and composition for regulating apoptosis |
| US6060238A (en) * | 1995-02-13 | 2000-05-09 | The Regents Of The University Of Michigan | Method and composition for regulating apoptosis |
| US7807783B1 (en) | 1995-04-03 | 2010-10-05 | The Regents Of The University Of Michigan | Methods and compositions for regulating FAS-associated apoptosis |
| US6747138B1 (en) | 1995-04-03 | 2004-06-08 | Regents Of The University Of Michigan | Methods and compositions for regulating Fas-associated apoptosis |
| US5672500A (en) | 1995-05-18 | 1997-09-30 | Thomas Jefferson University | Mch2, an apoptotic cysteine protease, and compositions for making and methods of using the same |
| US6635738B2 (en) | 1996-03-04 | 2003-10-21 | The Trustees Of Columbia University In The City Of New York | Compounds which prevent neuronal cell death and uses thereof |
| US6558900B2 (en) * | 1996-07-12 | 2003-05-06 | Emory University | Regulation of apoptosis and in vitro model for studies thereof |
| JP4777489B2 (ja) * | 1997-03-31 | 2011-09-21 | ザ チルドレンズ メディカル センター コーポレーション | アポトーシス性酵素を不活性化するためのニトロシル化 |
| US6455296B2 (en) * | 1997-05-29 | 2002-09-24 | Thomas Jefferson University | Apoptotic protease Mch6, nucleic acids encoding same and methods of use |
| US6270980B1 (en) * | 1997-06-05 | 2001-08-07 | Idun Pharmaceuticals, Inc. | Rapid methods for identifying modifiers of cellular apoptosis activity |
| CN1300828A (zh) * | 1999-12-22 | 2001-06-27 | 上海博德基因开发有限公司 | 一种新的多肽-半胱氨酸蛋白酶10和编码这种多肽的多核苷酸 |
| US6566135B1 (en) * | 2000-10-04 | 2003-05-20 | Isis Pharmaceuticals, Inc. | Antisense modulation of caspase 6 expression |
| DE10241152A1 (de) * | 2002-09-05 | 2004-03-18 | GESELLSCHAFT FüR BIOTECHNOLOGISCHE FORSCHUNG MBH (GBF) | Tubulysin-Biosynthese-Gene |
| US7410765B2 (en) * | 2004-11-17 | 2008-08-12 | The Regents Of The University Of California | System for protease mediated protein expression |
| WO2009117539A2 (en) * | 2008-03-19 | 2009-09-24 | Abbott Laboratories | Bioluminescent construct |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4873191A (en) * | 1981-06-12 | 1989-10-10 | Ohio University | Genetic transformation of zygotes |
| US4736866B1 (en) * | 1984-06-22 | 1988-04-12 | Transgenic non-human mammals | |
| US5108921A (en) * | 1989-04-03 | 1992-04-28 | Purdue Research Foundation | Method for enhanced transmembrane transport of exogenous molecules |
| ATE312198T1 (de) * | 1993-04-05 | 2005-12-15 | Univ Utah Res Found | Diagnose und behandlung von supravalvular aortic stenosis |
| US5672500A (en) * | 1995-05-18 | 1997-09-30 | Thomas Jefferson University | Mch2, an apoptotic cysteine protease, and compositions for making and methods of using the same |
-
1995
- 1995-05-18 US US08/446,925 patent/US5672500A/en not_active Expired - Lifetime
-
1996
- 1996-05-16 JP JP8535039A patent/JPH11505705A/ja active Pending
- 1996-05-16 DE DE69623786T patent/DE69623786T2/de not_active Expired - Lifetime
- 1996-05-16 WO PCT/US1996/007010 patent/WO1996036698A1/en not_active Ceased
- 1996-05-16 CA CA2221409A patent/CA2221409C/en not_active Expired - Lifetime
- 1996-05-16 AT AT96920234T patent/ATE224443T1/de not_active IP Right Cessation
- 1996-05-16 ES ES96920234T patent/ES2183960T3/es not_active Expired - Lifetime
- 1996-05-16 EP EP96920234A patent/EP0842267B1/de not_active Expired - Lifetime
-
1997
- 1997-07-18 US US08/896,885 patent/US5985640A/en not_active Expired - Lifetime
-
1998
- 1998-09-02 US US09/146,331 patent/US5958720A/en not_active Expired - Lifetime
-
1999
- 1999-08-16 US US09/375,256 patent/US6359127B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US6359127B1 (en) | 2002-03-19 |
| CA2221409A1 (en) | 1996-11-21 |
| CA2221409C (en) | 2011-07-26 |
| US5672500A (en) | 1997-09-30 |
| EP0842267A1 (de) | 1998-05-20 |
| DE69623786T2 (de) | 2003-05-15 |
| US5985640A (en) | 1999-11-16 |
| EP0842267A4 (de) | 2000-04-26 |
| JPH11505705A (ja) | 1999-05-25 |
| EP0842267B1 (de) | 2002-09-18 |
| DE69623786D1 (de) | 2002-10-24 |
| ES2183960T3 (es) | 2003-04-01 |
| US5958720A (en) | 1999-09-28 |
| WO1996036698A1 (en) | 1996-11-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE224443T1 (de) | Mch2, eine apoptotische cystein-protease, zusammensetzungen für ihre präparation und methoden für ihre verwendung | |
| Wold et al. | Identification of cellular proteins required for simian virus 40 DNA replication | |
| Nagy et al. | Glyceraldehyde-3-phosphate dehydrogenase selectively binds AU-rich RNA in the NAD+-binding region (Rossmann fold) | |
| Walz et al. | Generation of the neutrophil-activating peptide NAP-2 from platelet basic protein or connective tissue-activating peptide III through monocyte proteases. | |
| KR960705850A (ko) | 사람 쿠니즈형 프로테아제 저해인자(human kunitz-type protease inhibitors) | |
| Traut et al. | Ribosomal proteins of Escherichia coli. I. Demonstration of different primary structures. | |
| AR006188A1 (es) | "composicion farmaceutica para inhibir la actividad de serinproteasa, metodo in vitro para inhibir la actividad de serinproteasa y metodo para preparar dicha composicion". | |
| ATE79138T1 (de) | Typenspezifische papillomavirus-dns-sequenzen und peptide. | |
| MX9708427A (es) | Serpina derivada de pancreas. | |
| KR950032279A (ko) | 인체의 프로그램된 세포 사멸과 관련 있는 펩티드 및 이를 암호하는 디엔에이(dna) | |
| ES2259190T3 (es) | Composiciones y metodos para la biosintesis de taxol. | |
| AR056723A2 (es) | Polipeptido purificado metodo para producirlo , metodo para identificarlo y/ o aislarlo composicion farmaceutica que lo comprende, secuencia de acidos nucleicos aislada que codifica dicho polipeptido, vector que contiene a dicha secuencia celula huesped transfectada por dicho vector, sonda nucleotid | |
| DK0585285T3 (da) | Stabiliserede enzymer | |
| KR970707162A (ko) | II종 포스포리파제 A2 저해작용을 갖는 신규한 모노클로날 항체 및 그 일부를 포함하는 단백질(Novel monoclonal antibody having inhibitory effect on type II phospholipase A2 and protein containing a part of the same) | |
| ES2338285T3 (es) | Nuevos genes especificos de la capa de celulas basales de transferencia del endospermo (betl). | |
| EP0458937A4 (en) | Variants of pai-2 | |
| CA2281955A1 (en) | Ikb kinase, subunits thereof, and methods of using same | |
| ATE464320T1 (de) | Ntb-a, ein oberflächenmolekül impliziert in der aktivität natürlicher killerzellen (nk) | |
| Hiltkel et al. | Structure/function analysis of human cystatin SN and comparison of the cysteine proteinase inhibitory profiles of human cystatins C and SN | |
| Reddy et al. | Nucleotides sequence of the genes for the simian virus 40 proteins VP2 and VP3. | |
| McClelland et al. | The calpain—calpastatin system in vascular smooth muscle | |
| DE69510782D1 (de) | DNA, WELCHE FÜR DEN VORLÄUFER DES INTERLEUKIN-1 BETA KONVERTIERENDEN ENZYMS KODIERT (ICE rel-II) | |
| Rickli et al. | Investigations on the primary structure of human plasminogen further evidence for sequence homology | |
| ATE213773T1 (de) | In apoptosis beteiligte cysteine protease cmh-1 und dns-sequenzen dafür | |
| Harris et al. | Amino acid sequences in penicillo-pepsin: evidence for homology with porcine pepsin and chymosin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |